AA / Kinshasa / Pascal Mulegwa
A second death from Ebola virus disease was recorded Wednesday in the eastern Democratic Republic of the Congo (DRC) after the resurgence of the disease for a week, Congolese authorities and the World Organization announced on Sunday. health (WHO).
“This is a 42-year-old woman with an epidemiological and familial link with the first case of death, a two-year-old child, registered on October 6,” Dr Michel Tosalisana told Anadolu Agency, chief doctor of the Beni health zone, in the province of North Kivu.
The initial genomic sequencing indicates that the new cases probably represent a new surge of the epidemic from 2018 to 2020, according to the WHO, which has dispatched a dozen experts to the region to support the response.
Vaccination against Ebola virus disease began on Wednesday in the city of Beni. It was since October 8 that this new Ebola epidemic was declared, only five months after the end of the twelfth epidemic which lasted for three months in the neighboring region of Lubero.
According to the WHO, Ebola is spread through direct contact with blood and body fluids (urine, stool, saliva, vomiting, breast milk, sweat and semen) and objects that have been contaminated by a person with Ebola. .
The virus is also spread through contact with sick or dead wildlife. The DRC is the cradle of Ebola which has already raged thirteen times on its territory since its discovery in 1976 in the north – west facade by Congolese researchers, only one of whom has remained alive. [ Ndlr … professeur Jean – Jacques Muyembe ] and leads the INRB and several outbreak responses.
This researcher has developed “Ebanga”, a treatment molecule against Ebola. It was brought to the market after being approved by the United States Medicines Agency (FDA).
Other treatments have shown some efficacy against hemorrhagic fever, as have vaccines that are very protective.
. . (HAS), ..